Heart rhythm breakthrough? common diabetes drug may tame irregular heartbeats
NCT ID NCT03603912
Summary
This study is testing whether a diabetes medication called metformin and lifestyle changes can reduce how often and how long patients experience atrial fibrillation (AFib). It involves 175 people who already have heart devices that can monitor their heart rhythm. Researchers want to see if these approaches can help control AFib and prevent it from getting worse over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.